model portfolio

• 10/23/2024

  Revolutionizing Healthcare Investing: A Quantitative Approach to Precision Medicine

• 10/20/2024

  Wolfspeed: Poised for Explosive Growth

• 10/19/2024

  Protagonist Therapeutics: Solid Outlook, But Is the Stock Worth It?

• 10/9/2024

  **October’s Top Dividend Pick: Greystone Housing**

• 10/8/2024

  **CureVac’s Setback**

• 

  10/5/2024

  **Sleep Your Way to Riches: 2 Juicy Dividends for a Dream Retirement**

• 

  10/4/2024

  **Mirum Pharmaceuticals: Wait for Data Before Buying**

• 10/1/2024

  **Investing in Fixed Income**

• 9/30/2024

  **Pessimistic About a Soft Landing**

• 9/30/2024

  **AT&T: A 5% Yield Bargain**